A phase II, sham-controlled, double-blinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: study protocol for a randomized controlled trial

A phase II, sham-controlled, double-blinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: study protocol for a randomized controlled trial

Background A growing population of patients lives with severe coronary artery disease not amenable to coronary revascularization and with refractory angina despite optimal medical therapy. Percutaneous reduction of the coronary sinus is an emerging treatment for myocardial ischemia that increases c...

Full description

Bibliographic Details
Main Authors: Jolicœur, E. Marc, Banai, Shmuel, Henry, Timothy D., Schwartz, Marc, Doucet, Serge, White, Christopher J., Edelman, Elazer R., Verheye, Stefan
Other Authors: Harvard University--MIT Division of Health Sciences and Technology
Format: Article
Language:English
Published: BioMed Central Ltd. 2013
Online Access:http://hdl.handle.net/1721.1/77976
https://orcid.org/0000-0002-7832-7156

Internet

http://hdl.handle.net/1721.1/77976
https://orcid.org/0000-0002-7832-7156

Similar Items